Kasim Kutay

rdf:langString Kasim Kutay

rdf:langString Kasim Kutay

rdf:langString Kasim Kutay

rdf:langString United Kingdom

rdf:langString BSc. and MSc. - London School of Economics

rdf:langString Maha Arakji Kutay

rdf:langString Kasim Kutay (born 13 May 1965) is the CEO of Novo Holdings A/S, an investment fund that manages investments and assets for the Novo Nordisk Foundation. He holds British citizenship. Novo Holdings is one of the worlds largest life science investors, managing assets worth approximately DKK 710 billion Danish Kroners (approximately $106bn). Kasim Kutay is a former investment banker, focusing on the healthcare sector. Kasim Kutay assumed the role of CEO at Novo Holdings A/S on September 1, 2016, following the departure of Eivind Kolding. Kasim Kutay joined Novo Holdings A/S after more than two decades working within investment banking. He began his career at the investment bank Morgan Stanley in 1989, rising to the post of chairman of its European Healthcare Group. After 18 years at Morgan Stanley, Kasim Kutay worked at a private US investment firm, Sun Group, prior to joining Moelis & Company in 2009. He joined Moelis & Company in 2009, where he worked for seven years, serving as Co-head of Europe and member of its Management Committee until he joined Novo Holdings A/S in 2016. Kasim Kutay is a member of the board of directors at Novozymes, Novo Nordisk A/S, and a former board member of Convatec up until July 3 - 2018. Kasim Kutay is also a charity board member of the t.